The Effect of Capecitabine as Adjuvant Therapy for Curatively Resected Biliary Tract Cancer

DOI QR Code

담도암에서 근치적 절제술 후 보조 항암 요법으로 capecitabine 단독 요법의 효과

Hee Ryeong Jang (Department of Internal Medicine, Kangwon National University School of Medicine) ;
Kyu-Hyoung Lim (Department of Internal Medicine, Kangwon National University School of Medicine)

Brindley PJ, Bachini M, Ilyas SI, et al. Cholangiocarcinoma. Nat Rev Dis Primers 2021;7:65. https://doi.org/10.1038/s41572-021-00300-2
Edeline J, Benabdelghani M, Bertaut A, et al. Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study. J Clin Oncol 2019;37:658-667. https://doi.org/10.1200/JCO.18.00050
Ebata T, Hirano S, Konishi M, et al. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer. Br J Surg 2018;105:192-202. https://doi.org/10.1002/bjs.10776
Nakachi K, Ikeda M, Konishi M, et al. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet 2023;401:195-203. https://doi.org/10.1016/S0140-6736(22)02038-4
Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 2019;20:663-673. https://doi.org/10.1016/S1470-2045(18)30915-X Erratum in: Lancet Oncol 2019;20:e242. https://doi.org/10.1016/S1470-2045(19)30216-5
Bridgewater J, Fletcher P, Palmer DH, et al. Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study. J Clin Oncol 2022;40:2048-2057. https://doi.org/10.1200/JCO.21.02568